Study of tumor margins in pancreatic cancer surgery
Part of Cancer clinical trials.
This study looks at how the surgeon's cutting edges (margins) and the way the tumor sits in the pancreas affect outcomes for people having surgery for pancreatic cancer. By joining, you'll help researchers learn how to improve surgery and planning for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You are scheduled to have surgery to remove your pancreatic tumor, either as your first treatment or after receiving chemotherapy before surgery.
- The hospital where you are treated must use a specific method (the Leeds Pathology Protocol) to examine the cancer margins under a microscope.
- You must have had a special CT scan (called biphasic CT) before surgery. If you had chemotherapy first, you need CT scans both before and after the chemotherapy.
- Your surgical details (like whether parts of the pancreas or blood vessels were removed) must be fully documented.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with borderline-resectable or locally advanced pancreatic cancer to see how treatment choices affect survival, quality of life, and whether tumors can be removed by surgery. It may help doctors better predict who can benefit from surgical approaches and what outcomes matter most to patients.
This study looks at what features of certain pancreas and nearby tumors or cysts might help predict outcomes. It uses existing medical records (and consent, if applicable) and may help doctors better estimate prognosis for patients in the future.
This study looks at MRI scans, computer-extracted imaging features, and blood/“liquid biopsy” tests after FOLFIRINOX chemotherapy to predict whether surgery can fully remove pancreatic cancer. It may help your care team choose the best next step—whether surgery is likely to be possible and how to plan it.
This study is looking at genetic material and proteins from pancreatic tumors to understand how the cancer responds to treatment. It aims to help doctors choose the best therapies for patients with certain types of pancreatic cancer that can be removed surgically or that have not spread to other organs.
This study looks at using a special blood test (ctDNA MRD) to track how well the tumor responds to chemotherapy before surgery for pancreatic cancer. It may help doctors decide if the treatment is working and guide next steps.
This study looks at patients who had surgery to remove pancreatic cancer to understand what factors might lead to the cancer coming back early. If you have had surgery for pancreatic cancer and are interested in helping researchers learn more, this may be a fit.
Hear when a new PDAC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.